Thousands of women take DIY smear tests at home to help promote screening.
It is hoped that pilots will encourage women who are too embarrassed to be examined by general practitioners and health center health care professionals.
If successful, medical professionals say it could soon be rolled out nationwide.
A test looking for a strain of human papillomavirus (HPV) that is involved in 99% of cases of cervical cancer is posted to women aged 25-64 years who are 15 months late.
The NHS screening program invites all women over the age of 25 to regular cotton swabs. It starts with a reservation once every three years and decreases to once every five years for those over 50 years old.
The HPV vaccine used in 2008 is expected to eliminate most of the virus from the UK in the next generation, but women who were 12 years old before that may still be at risk for the virus. there is.
The HPV virus spreads through sexual activity and, in most cases, does not cause symptoms or serious harm, but it can increase the risk of cancer in later years.
Cervical cancer can develop at a young age, often affecting women in their 30s and 40s, and about half of women who develop cervical cancer die within 10 years of diagnosis. I will.
The smear test is a cotton swab performed in the vagina that can detect HPV, the sexually transmitted disease virus that causes almost all cases of cervical cancer (stock image).
Dr. Anitalim of King’s College London, who is leading the study, said self-sampling is a “game changer for cervical screening.”
She states: “We know that many women do not participate in screening and that nearly half of women in some parts of London do not have the latest information on cervical screening.
“Even though this is an intimate procedure and can be a life-saving test, various barriers can prevent people from participating.
“This simple and convenient swab means you can do it within the privacy and comfort of your own home.
HPV vaccine “I was able to eradicate cervical cancer”
The UK Public Health Service said last year that the HPV vaccine could almost eliminate cervical cancer in young women.
Real-world data show that HPV infection has infected 15% to less than 2% of women in just 10 years after the vaccine was used.
HPV causes almost all cases of cervical cancer, and many experts believe that stopping the spread of HPV can eliminate cervical cancer in the United Kingdom.
“According to our analysis, the near-full efficacy of HPV vaccination in the trial has been achieved in the real world,” said Professor Peter Sasieni, who conducted a study on the effectiveness of the vaccine.
“These results suggest that the impact of HPV vaccination on the prevention of cervical cancer may be even greater than previously estimated.”
This vaccine was developed to prevent the spread of HPV types 6, 11, 16 and 18.
Types 16 and 18 cause more than 70% of cases of cervical cancer in the United Kingdom, and types 6 and 11 cause 90% of cases of genital warts. The jab protects from both.
Professor Sasieni’s work used data from a review that combined 65 other studies from 14 countries.
Jab was found to be 92% effective within 4 years of being given. Effective 99.8% after 5 years. Overall, it has a 97.6% effect.
Cancers of both the male and female reproductive organs and reproductive system, as well as the rectum, mouth and throat, can all be associated with the HPV virus.
A report released in February 2019 predicted that cancer cases would be cut in half by 2050 and completely eradicated by 2100.
Professor Sasieni’s letter was published in a medical journal Lancet..
“Women who do not come to regular screening are at greatest risk of developing cervical cancer, so find such a way to facilitate screening and protect women from cancer that is mostly preventable. Is important. ”
Screening for the disease in the UK has been the lowest ever, with about 5 million women currently postponing testing.
Almost one-third of British women are at risk because they ignored their latest invitation and went for years without a smear test.
Experts believe that by providing an opportunity to test the privacy and comfort of their home, they can appeal to many women who are too embarrassed or too busy to attend the clinic.
Studies show that DIY kits can increase screening for these hard-to-reach groups by up to 50%.
The exam is intended for people living in the London Borough of Barnett, Camden, Islinton, Newham and Tower Hamlets, where screening appointments are low.
Home kits will also be provided to women who are six months late in the trial and are participating in the GP surgery associated with the trial.
“This is an important new way to facilitate screening for thousands of women,” said Professor Peter Johnson, National Clinical Director of Cancer at the NHS in the United Kingdom.
“We know that there are many reasons why women may not attend screening appointments, including concerns about Covid.
“GP has taken special precautions to make surgery safe, and these home kits offer thousands of women another option to keep their screening up-to-date.
“We encourage all women to make sure they have a smear test. HPV should be detected early. It may save your life.”
Women participating in a YouScreen trial jointly conducted by NHS England, Public Health England and King’s College London will follow the test instructions and post cotton swabs for analysis.
They will receive the results in the post and will be contacted regarding follow-up appointments if HPV is detected.
Ruth Stubbs, PHE’s National Cervical Screening Program Manager, said it was the first step for women across the UK to approach HPV self-sampling at home.
She states: ‘PHE is also working on a clinical validation study to inform a larger national assessment of HPV self-sampling at home.
“This work, along with the results of the YouScreen London study, is from the UK to inform the UK National Screening Commission of the potential impact of providing HPV self-sampling for the prevention and early detection of cervical cancer. I will provide the data. ”
Kate Sanger of Jo’s Cervical Cancer Trust said: ‘Self-sampling eliminates many of the challenges of cervical cancer screening. Through our research, we found that women really wanted it.
“It’s great to be able to participate in this study and hope that the diagnosis of cervical cancer will lead to potentially life-saving and traumatic changes.”
What is HPV?Infections associated with 99% of cervical cancers
Up to 8 out of 10 people get HPV in their lives
Human papillomavirus (HPV) is the name of a group of viruses that affect the moist membranes that line the skin and the inside of the body.
Spreading through the vagina, anus, oral sex, skin-to-skin contact between the genitals, it is very common.
Up to 8 out of 10 people become infected with the virus at some point in their lives.
There are more than 100 types of HPV. About 30 of them can affect the genital area. Genital HPV infections are common and highly contagious.
Many people develop symptoms years after infection, so they are asymptomatic and most often disappear without treatment.
It can lead to genital warts and is also known to cause cervical cancer by causing abnormal tissue growth.
Each year, an average of 38,000 HPV-related cancers are diagnosed in the United States, 3,100 cervical cancers in the United Kingdom, and about 2,000 other cancers in men.
What other cancers does it cause?
NHS in London tries DIY cervical smear test for women who are late for cancer screening
SourceNHS in London tries DIY cervical smear test for women who are late for cancer screening